Pluristem | Market Exclusive

Home Tags Pluristem

Market Morning: Boeing Going On, Unemployment Confusion, Gilead Treatment, China Barely...

ME Staff - April 17, 2020 0

Pluristem Therapeutics Inc. (NASDSAQ:PSTI) To Begin CLI Phase III Trial Enrolling...

David Rich - January 11, 2017 0

Exclusive Interview With Pluristem Therapeutics Inc.(NASDAQ:PSTI) President Yaky Yanay

David Rich - November 29, 2016 0

Why Pluristem Therapeutics Inc. Is So Undervalued – The Market Is...

Rafi Farber - November 3, 2016 0

Pluristem Therapeutics Inc. (NASDAQ:PSTI) Gears Up For Critical Blood Stem Cell...

David Rich - September 19, 2016 0

Will Pluristem Therapeutics Inc. (NASDAQ:PSTI) Succeed in CLI Where Sanofi SA...

David Rich - August 11, 2016 0

Japan is Breathing Life into the Stem Cell Space, Astellas Pharma...

- July 21, 2016 1

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

December 9, 2024

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

November 24, 2024

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

November 18, 2024

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.

Tag: Pluristem

Market Morning: Boeing Going On, Unemployment Confusion, Gilead Treatment, China Barely...

Pluristem Therapeutics Inc. (NASDSAQ:PSTI) To Begin CLI Phase III Trial Enrolling...

Exclusive Interview With Pluristem Therapeutics Inc.(NASDAQ:PSTI) President Yaky Yanay

Why Pluristem Therapeutics Inc. Is So Undervalued – The Market Is...

Pluristem Therapeutics Inc. (NASDAQ:PSTI) Gears Up For Critical Blood Stem Cell...

Will Pluristem Therapeutics Inc. (NASDAQ:PSTI) Succeed in CLI Where Sanofi SA...

Japan is Breathing Life into the Stem Cell Space, Astellas Pharma...

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

POPULAR POSTS

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

POPULAR CATEGORY